Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Inclusion Body Myositis clinical trials
Every US clinical trial registered for Inclusion Body Myositis — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
11 US clinical trials · 3 currently recruiting
The research picture
Inclusion Body Myositis has 11 registered US clinical trials, 3 of them open to new participants right now — about 27% of the total.
- 3
- recruiting participants now
- 27%
- of trials open to enrollment
- 1
- in Phase 3–4 (later-stage)
- 3
- top sponsor: University of Kansas Medical Center
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Adult and Juvenile Myositis
National Institute of Environmental Health Sciences (NIEHS)
NCT00017914
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Myositis International Health & Research Collaborative Alliance Foundation
NCT07374107
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
University of Missouri-Columbia
NCT07478172
Sporadic Inclusion Body Myositis Natural History Study
University of California, Irvine
NCT05046821
Phase III Trial of Sirolimus in IBM
University of Kansas Medical Center
NCT04789070
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
University of Kansas Medical Center
NCT06153108
Establishing Muscle Impedance Parameters With Electrical Impedance Myography
Yale University
NCT03633318
Lithium in Inclusion Body Myositis (IBM)
Phoenix Neurological Associates
NCT00917956
Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis
Washington University School of Medicine
NCT00802815
Study of Pioglitazone in Sporadic Inclusion Body Myositis
Johns Hopkins University
NCT03440034
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
University of Kansas Medical Center
NCT04975841
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Inclusion Body Myositis Trial Landscape
ClinicalTrials.gov lists 11 US studies indexed under Inclusion Body Myositis, and 3 of those are currently open to recruitment — roughly 27% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Inclusion Body Myositis shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Inclusion Body Myositis is led by University of Kansas Medical Center with 3 indexed trials, alongside 8 other organizations in the top contributor list. The list on this page surfaces up to 11 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Inclusion Body Myositis?
PlainTrial tracks 11 US clinical trials for Inclusion Body Myositis, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Inclusion Body Myositis?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.